Antimicrobial Agents and Chemotherapy · 2009 · 58 citations · 20 references
PharmacyPharmacokineticsPharmacologyBioavailabilityPopulation PharmacokineticsRenal PharmacokineticsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyImmunosuppression In Kidney TransplantationPharmacokinetics In Renal ImpairmentTransplant PharmacokineticsDose Adjustment AssessmentDose Adjustment CriteriaIntercompartmental ClearancePharmacokinetic Absorption ParametersPharmacokinetic ParametersPharmacokinetics In TransplantationPost-transplant Cytomegalovirus InfectionRenal Function Covariates
A population pharmacokinetics analysis was performed after intravenous ganciclovir and oral valganciclovir in solid organ transplant patients with cytomegalovirus. Patients received ganciclovir at 5 mg/kg of body weight (5 days) and then 900 mg of valganciclovir (16 days), both twice daily with dose adjustment for renal function. A total of 382 serum concentrations from days 5 and 15 were analyzed with NONMEM VI. Renal function given by creatinine clearance (CL(CR)) was the most influential covariate in CL. The final pharmacokinetic parameters were as follows: ganciclovir clearance (CL) was 7.49.(CL(CR)/57) liter/h (57 was the mean population value of CL(CR)); the central and peripheral distribution volumes were 31.9 liters and 32.0 liters, respectively; intercompartmental clearance was 10.2 liter/h; the first-order absorption rate constant was 0.895 h(-1); bioavailability was 0.825; and lag time was 0.382 h. The CL(CR) was the best predictor of CL, making dose adjustment by this covariate important to achieve the most efficacious ganciclovir exposure.
20
Bootstrap Methods: Another Look at the Jackknife
B. Efron · The Annals of Statistics · 1979 · 17.4K citations · Full text
Delafield Du Bois · Archives of internal medicine · 1916 · 4.3K citations
Medicine, Pediatrics, Physiology +15